Amicus Therapeutics | Advancing Therapies to Treat Rare Diseases
Amicus Therapeutics) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering high-quality medicines for people living with rare metabolic diseases.
Total Visits
Avg. Visit Duration
Pages per Visit
Bounce Rate
Registration Date
| Month | Traffic |
|---|---|
| 2025-02 | 11.286 |
| 2025-03 | 15.801 |
| 2025-04 | 13.504 |
| Source | Traffic Share |
|---|---|
| search | 46.23% |
| direct | 39.02% |
| social | 7.23% |
| referrals | 6.38% |
| paid referrals | 1.02% |
| 0.08% |
| Region | Percentage |
|---|---|
| United States | 66.15% |
| India | 11.61% |
| United Kingdom | 10.64% |
| Canada | 5.37% |
| ES | 3.98% |
| Keyword | Traffic | Volume | CPC |
|---|---|---|---|
| amicus therapeutics | 317 | 3,170 | $3.55 |
| amicu first perspn accounts edinburgh | 4 | 40 | $0.00 |
| amicus | 2,794 | 27,940 | $1.09 |
| pombiliti pregnancy placenta | 5 | 50 | $0.00 |
| amius fabry revenue | 3 | 30 | $0.00 |